Janus Henderson Group
AMED

Janus Henderson Group’s Amedisys AMED Stock Holding History

Janus Henderson Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-72,736
Closed -$7.16M – 2399
2025
Q2 		$7.16M Sell
72,736
-6,245
-8% -$591K ﹤0.01% 801
2025
Q1 		$7.33M Sell
78,981
-13,715
-15% -$1.26M ﹤0.01% 773
2024
Q4 		$8.42M Hold
92,696
– – ﹤0.01% 763
2024
Q3 		$8.95M Hold
92,696
– – ﹤0.01% 709
2024
Q2 		$8.51M Sell
92,696
-193,072
-68% -$17.9M ﹤0.01% 701
2024
Q1 		$26.3M Sell
285,768
-83,985
-23% -$7.87M 0.01% 516
2023
Q4 		$35.1M Sell
369,753
-103,750
-22% -$9.69M 0.02% 442
2023
Q3 		$44.2M Sell
473,503
-23,933
-5% -$2.21M 0.03% 386
2023
Q2 		$45.5M Buy
497,436
+482,999
+3,346% +$39.6M 0.03% 402
2023
Q1 		$1.06M Sell
14,437
-6,840
-32% -$592K ﹤0.01% 1595
2022
Q4 		$1.78M Sell
21,277
-23,917
-53% -$2.16M ﹤0.01% 1134
2022
Q3 		$4.37M Buy
45,194
+24,769
+121% +$2.95M ﹤0.01% 1030
2022
Q2 		$2.15M Sell
20,425
-923
-4% -$118K ﹤0.01% 1022
2022
Q1 		$3.68M Sell
21,348
-6,227
-23% -$930K ﹤0.01% 1077
2021
Q4 		$4.46M Buy
27,575
+835
+3% +$134K ﹤0.01% 1092
2021
Q3 		$3.99M Buy
26,740
+2,417
+10% +$502K ﹤0.01% 1108
2021
Q2 		$5.96M Buy
24,323
+404
+2% +$106K ﹤0.01% 1027
2021
Q1 		$6.33M Buy
23,919
+2,152
+10% +$607K ﹤0.01% 974
2020
Q4 		$6.38M Buy
21,767
+2,993
+16% +$767K ﹤0.01% 922
2020
Q3 		$4.44M Buy
18,774
+4,571
+32% +$1.04M ﹤0.01% 930
2020
Q2 		$2.82M Buy
14,203
+7,419
+109% +$1.38M ﹤0.01% 986
2020
Q1 		$1.25M Sell
6,784
-349
-5% -$62.1K ﹤0.01% 1073
2019
Q4 		$1.19M Sell
7,133
-1,434
-17% -$213K ﹤0.01% 1214
2019
Q3 		$1.12M Buy
8,567
+3,360
+65% +$437K ﹤0.01% 1211
2019
Q2 		$632K Buy
5,207
+803
+18% +$95.3K ﹤0.01% 1241
2019
Q1 		$543K Buy
4,404
+54
+1% +$6.78K ﹤0.01% 1235
2018
Q4 		$509K Sell
4,350
-395
-8% -$46.6K ﹤0.01% 1227
2018
Q3 		$593K Buy
4,745
+471
+11% +$52K ﹤0.01% 1306
2018
Q2 		$365K Sell
4,274
-677
-14% -$49.7K ﹤0.01% 1316
2018
Q1 		$299K Buy
+4,951
New +$282K ﹤0.01% 1310
2017
Q4 		– Sell
-4,144
Closed -$232K – 1304
2017
Q3 		$232K Sell
4,144
-289
-7% -$15.3K ﹤0.01% 1267
2017
Q2 		$278K Buy
+4,433
New +$258K ﹤0.01% 1277

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janus Henderson Group's AMED Position: Q3 2025 in Review

Janus Henderson Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 72,736 shares — an estimated $7.16M sold.

Janus Henderson Group first reported a position in AMED in Q2 2017 and held it in 32 quarters. The position peaked at $45.5M in Q2 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Janus Henderson Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 72,736 Amedisys shares in Q3 2025, an estimated $7.16M.
  • Janus Henderson Group first reported a position in Amedisys in Q2 2017 and held it in 32 quarters.
  • Janus Henderson Group's Amedisys position peaked at $45.5M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.